CRITLEVEL: An Exploratory Procedure for the Evaluation of Quantitative Prognostic Factors

U. Abel; Jutta Berger; H. Wiebelt

doi:10.1055/s-0038-1635335

Methods of Information in Medicine, Inhaltsverzeichnis

Methods Inf Med 1984; 23(03): 154-156
DOI: 10.1055/s-0038-1635335

Original Article

Schattauer GmbH

CRITLEVEL: An Exploratory Procedure for the Evaluation of Quantitative Prognostic Factors

CRITLEVEL: Ein exploratives Verfahren zur Auswertung quantitativer prognostischer Faktoren

Authors

U. Abel

¹(From the German Cancer Research Center, Heidelberg, Institute of Documentation, Information and Statistics; Director: Prof. Dr. G. Wagner)
Jutta Berger

¹(From the German Cancer Research Center, Heidelberg, Institute of Documentation, Information and Statistics; Director: Prof. Dr. G. Wagner)
H. Wiebelt

¹(From the German Cancer Research Center, Heidelberg, Institute of Documentation, Information and Statistics; Director: Prof. Dr. G. Wagner)

Abstract

Summary

CRITLEVEL is a simple but efficient graphic tool for determining those levels of quantitative prognostic factors at which the most pronounced deterioration of prognosis takes place.

CRITLEVEL ist ein einfaches, aber effizientes Verfahren zur Bestimmung derjenigen Werte quantitativer prognostischer Faktoren, bei denen die ausgeprägteste Prognoseverschlechterung eintritt.

Key-Words:

Prognostic Factors - Critical Values - Failure Time Analysis

Schlüssel-Wörter:

Prognostische Faktoren - kritischer Wert - Failure-time-Analyse

Volltext

Referenzen

References
1 Breslow A.. Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous Melanoma. Ann. Surgery 1975; 182: 572-75.
2 Cox D. R.. Regression Models and Life Tables. J. roy. Statist. Soc. B 1972; 34: 187-202.
3 Day (Jr.) C. L., Fitzpatrick T. B., Harris M. N., Kopf A. W., Lew R. A., Mihm M. C, Sober A. J.. The Natural Breakpoints for Primary-Tumor Thickness in Clinical I Stage Melanoma. New Engl. J. Med 1981; 1155; 305
4 Edler L., Abel U., Fritze D., Massner B., Becher R., Kaufmann M., Hartlapp J., Queisser W., Mayr A. C, Drings P., Westerhausen M., Jungi W. F., Senn H. J.. Statistical Evaluation of the Multicenter Metastatic Breast Cancer Trial OSAKO 11/ 77 of Combination Chemotherapy (VAC-FMC) with Immunostimulation by Cory-nebacterium Parvum with Different Forms of Application. Techn. Report 2/83, Dep. of Biostatistics, DKFZ, Heidelberg 1983
5 Heite H. J.. Die Arbeitsgemeinschaft Malignes Melanom der DFG - das Modell einer durch Dokumentationsprogramme gelenkten Gemeinschaftsforschung. Der niedergelassene Arzt 1976; 25: 128-32.
6 Kendall M. G., Stuart A.. The Advanced Theory of Statistics. Vol 1. London: C. Griffin & Co 1963
7 Peto R., Pike M. C, Armitage P., Breslow N. F., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P.G.. Design and Analysis of Ran-domized Clinical Trials Requiring Prolonged Observation of Each Patient. Part II: Analyses and Examples. Brit. J. Cancer 1977; 35: 1-39.
8 Sidak Z.. Rectangular Confidence Regions for the Means of Multivariate Normal Distributions. J. Amer. Statist. Assoc 1967; 62: 626-33.
9 Weber E.. (Ed) SURVIVAL. Statistische Auswertung biomedizinischer Daten. Teil II: Analyse zensierter Beobachtungen. Inst. für Dokumentation, Information und Statistik, DKFZ, Heidelberg 1982